Brief: TCR² Therapeutics Reports Q2 Loss Per Share $0.46
08/08/2019 12:13
Aug 8 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS REPORTS SECOND QUARTER 2019 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* TCR2 THERAPEUTICS INC QTRLY LOSS PER SHARE $0.46
* TCR2 THERAPEUTICS INC - ENDED Q2 OF 2019 WITH $180.7
MILLION IN
CASH, CASH EQUIVALENTS
Source text for Eikon: ID:nGNX8WJPX4
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview